Medicare Enrolled
Dr. Matthew McClure, M.D.
Internal Medicine · Williamsville, NY
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McClure from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McClure?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McClure
Dr. Matthew McClure is an internal medicine specialist in Williamsville, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. McClure performed 3,220 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. McClure received a total of $7,104 from 48 pharmaceutical and/or device companies across 430 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McClure is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 11% volume in NY
$7,104 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,220
Medicare services
Top 11% in NY for internal medicine
Not available
Unique patients (not deduplicated)
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
1,264 | $6 | $34 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
329 | $9 | $154 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
320 | $87 | $404 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
246 | $57 | $168 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
156 | $4 | $10 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
104 | $39 | $74 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
89 | $46 | $356 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
75 | $318 | $701 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
63 | $91 | $241 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
49 | $46 | $240 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
42 | $15 | $190 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
37 | $50 | $337 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
36 | $94 | $473 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
35 | $38 | $142 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
34 | $136 | $388 |
| Perflutren lipid microspheres injection Injection of perflutren lipid microspheres, measured per milliliter. |
33 | $33 | $202 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
30 | $175 | $475 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
30 | $89 | $246 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
29 | $2 | $71 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $110 | $311 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
27 | $142 | $186 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
23 | $27 | $167 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
22 | $18 | $114 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
20 | $25 | $311 |
| 2-day continuous ECG monitoring A continuous electrocardiogram recording that captures heart activity over a 48-hour period. This test helps detect irregular heart rhythms or other cardiac issues that may not appear during a standard, short-term ECG. |
19 | $13 | $227 |
| 2-day continuous ECG with professional review A two-day continuous electrocardiogram recording that includes a review by a healthcare professional. |
19 | $12 | $150 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
19 | $18 | $66 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
16 | $6 | $60 |
| Ultrasound of leg arteries or grafts An ultrasound exam that uses sound waves to create images of the arteries in one leg or any grafts present in that leg. |
16 | $91 | $218 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
11 | $20 | $68 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
14.6% high complexity
15.8% medium
69.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,104
Total received (2018-2024)
Avg $1,015/year across 7 years
Top 12% in NY for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
430
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,297
2023
$1,359
2022
$1,248
2021
$793
2020
$232
2019
$1,087
2018
$1,089
Payments by company (2024)
Amgen Inc.
$194
E.R. Squibb & Sons, L.L.C.
$160
Boehringer Ingelheim Pharmaceuticals, Inc.
$96
PFIZER INC.
$93
Kiniksa Pharmaceuticals International, plc
$93
AstraZeneca Pharmaceuticals LP
$90
Novartis Pharmaceuticals Corporation
$87
Merck Sharp & Dohme LLC
$68
SCPHARMACEUTICALS INC.
$55
Abbott Laboratories
$47
Edwards Lifesciences Corporation
$47
Philips North America LLC
$38
Novo Nordisk Inc
$35
Impulse Dynamics (USA) Inc.
$27
BIOTRONIK NRO, Inc.
$27
Actelion Pharmaceuticals US, Inc.
$25
Regeneron Healthcare Solutions, Inc.
$24
Inspire Medical Systems, Inc.
$24
Janssen Pharmaceuticals, Inc
$19
Bayer Healthcare Pharmaceuticals Inc.
$18
Lexicon Pharmaceuticals, Inc.
$18
Esperion Therapeutics, Inc.
$14
Top 3 companies account for 34.7% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,161
Novartis Pharmaceuticals Corporation
$782
PFIZER INC.
$615
Boehringer Ingelheim Pharmaceuticals, Inc.
$441
Janssen Pharmaceuticals, Inc
$381
E.R. Squibb & Sons, L.L.C.
$337
Merck Sharp & Dohme LLC
$333
SANOFI-AVENTIS U.S. LLC
$315
AstraZeneca Pharmaceuticals LP
$295
Amarin Pharma Inc.
$179
BIOTRONIK INC.
$157
Daiichi Sankyo Inc.
$156
Novo Nordisk Inc
$155
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$153
Edwards Lifesciences Corporation
$136
Abbott Laboratories
$120
Impulse Dynamics (USA) Inc.
$108
Kowa Pharmaceuticals America, Inc.
$96
Kiniksa Pharmaceuticals International, plc
$93
SCPHARMACEUTICALS INC.
$89
Bayer HealthCare Pharmaceuticals Inc.
$82
Merck Sharp & Dohme Corporation
$80
Baxter Healthcare
$65
Alnylam Pharmaceuticals Inc.
$59
Boston Scientific Corporation
$58
Kiniksa Pharmaceuticals, Ltd.
$56
Regeneron Healthcare Solutions, Inc.
$55
Esperion Therapeutics, Inc.
$54
Takeda Pharmaceuticals U.S.A., Inc.
$47
ABIOMED
$39
Lexicon Pharmaceuticals, Inc.
$38
Philips North America LLC
$38
Bayer Healthcare Pharmaceuticals Inc.
$31
BOSTON SCIENTIFIC CORPORATION
$31
CardioFocus, Inc.
$27
BIOTRONIK NRO, Inc.
$27
Actelion Pharmaceuticals US, Inc.
$25
GENZYME CORPORATION
$24
Inspire Medical Systems, Inc.
$24
Astellas Pharma US Inc
$21
CARDIVA MEDICAL, INC.
$21
Otsuka America Pharmaceutical, Inc.
$17
PORTOLA PHARMACEUTICALS, INC.
$17
Allergan Inc.
$16
Medtronic Vascular, Inc.
$14
Lilly USA, LLC
$13
Lantheus Medical Imaging, Inc.
$12
Allergan, Inc.
$12
Top 3 companies account for 36.0% of all-time payments
Associated products mentioned in payments ›
(AO0) IGT Devices Intracardiac · AVEIR · Adempas · Arcalyst · BEVYXXA · BRILINTA · CAMZYOS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · Compia MRI · Corlanor · Definity · ELIQUIS · EMGALITY · ENTRESTO · EVKEEZA · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FABRAZYME · FARXIGA · FUROSCIX · GALLANT · Hillrom - Cardiac Ambulatory Monitor · INJECTAFER · INSPIRE · Impella · Inpefa · JARDIANCE · JOT DX · Kerendia · LEQVIO · LOKELMA · Lexiscan · LifeVest · Livalo · MULTAQ · NEXLETOL · ONPATTRO · OPSUMIT · OPTIMIZER · Optimizer · Ozempic · PRADAXA · PRALUENT · Prospera · QUADRA ASSURA · RESONATE · Repatha · Rybelsus · SAMSCA · SAPIEN 3 Ultra RESILIA · Trintellix · VERQUVO · VRAYLAR · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WATCHMAN Access System · XARELTO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
534
County median income
$71,175
Nearest hospital to ZIP centroid (approximate)
UPSTATE NEW YORK VA HEALTHCARE SYSTEM (WESTERN NY VA HEALTHCARE SYSTEM)
5.6 mi
5.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. McClure is a cardiac imaging specialist, with above-average Medicare volume (top 11% in NY), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. McClure experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. McClure performed 1,264 ekg interpretation and report services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. McClure receive payments from pharmaceutical companies?
Yes. Dr. McClure received a total of $7,104 from 48 companies across 430 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McClure's costs compare to other internal medicine physicians in Williamsville?
Dr. McClure's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McClure) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Williamsville
Browse internal medicine physicians in Williamsville ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NY
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NY
Which NY internal medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology